Literature DB >> 22269587

Social Anxiety/Taijin-Kyofu Scale (SATS): development and psychometric evaluation of a new instrument.

Satoshi Asakura1, Takeshi Inoue, Nobuki Kitagawa, Mifumi Hasegawa, Yutaka Fujii, Yuki Kako, Yasuya Nakato, Naoki Hashimoto, Koki Ito, Teruaki Tanaka, Shin Nakagawa, Ichiro Kusumi, Tsukasa Koyama.   

Abstract

BACKGROUND: Taijin-kyofu (TK), especially the 'convinced' subtype of TK (c-TK; also known as the 'offensive' subtype of TK), is described as a Japanese culture-bound syndrome similar to social anxiety disorder (SAD). Recently, in Western countries, the symptoms of c-TK have been investigated in patients with SAD. We developed the Social Anxiety/Taijin-Kyofu Scale (SATS), a 12-item structured clinician-rated instrument designed to rate the severity of TK symptoms, and examined its reliability and validity.
METHODS: The SATS was administered to 15 patients with c-TK diagnosed using the traditional Japanese TK criteria. Interviews used to score patients' symptoms were recorded on videotape. Additionally, the Clinical Global Impression-Severity Scale (CGI-S) was administered to assess convergent validity. Interrater reliability was assessed on 15 videotaped interviews; the interviews were independently rated by 10 other raters. Test-retest re-liability was assessed on 15 videotaped interviews by the same rater at an interval of more than 4 weeks.
RESULTS: The SATS had high internal consistency (Cronbach's α = 0.97) and good interrater reliability (ICC = 0.88-0.93) and test-retest reliability (ICC = 0.94-0.99). The SATS total score correlated with the CGI-S scores (r = 0.77, p < 0.0001).
CONCLUSION: The SATS appears to be a reliable and valid measure of the symptoms of TK.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22269587     DOI: 10.1159/000329741

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  1 in total

1.  Long-term administration of escitalopram in patients with social anxiety disorder in Japan.

Authors:  Satoshi Asakura; Taiji Hayano; Atsushi Hagino; Tsukasa Koyama
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-22       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.